Nasdaq Moves to Delist TELA Bio; Company Seeks Hearing to Halt Suspension
TELA has more than doubled off its 52-week low of $0.501 on elevated volume (2.4× avg).
Summary
TELA Bio received a formal delisting notice from Nasdaq after failing to regain the $1.00 minimum bid price within the grace period. The company will request a hearing to stay the delisting while it seeks shareholder approval for a reverse stock split at the October 8 special meeting.
Key Events · Legal and Risk Events · TELA
-
Nasdaq Delisting Notice Received
On September 15, 2026, Nasdaq Staff notified TELA Bio that its common stock is subject to delisting from the Nasdaq Global Market after the company failed to regain compliance with the $1.00 minimum bid price requirement within the 180-day grace period.
-
Hearing Request to Stay Delisting
The company intends to timely request a hearing before a Nasdaq Hearings Panel, which will automatically stay any suspension or delisting pending the conclusion of the hearings process.
-
Reverse Split Vote on October 8
TELA Bio filed a proxy statement on September 14, 2026 seeking shareholder approval for a reverse stock split at a ratio ranging from 1-for-5 to 1-for-15 to regain compliance; the special meeting is scheduled for October 8, 2026, and approval is not assured.
-
Compliance Path Requires Sustained $1.00 Bid
To regain compliance, the closing minimum bid price must be at least $1.00 per share for at least 10 consecutive business days and up to 20 consecutive business days, at the Staff's or Panel's discretion.
Analysis · TELA · Industrial Applications And Services
The Nasdaq has formally notified TELA Bio that its stock faces delisting after the company failed to regain compliance with the $1.00 minimum bid price requirement within the 180-day grace period. To counter this, the company plans to request a hearing before a Nasdaq Hearings Panel, a move that automatically stays any suspension or delisting while the process unfolds. This marks a critical escalation: the company's listing on the Nasdaq Global Market is now at immediate risk, and the outcome hinges on the October 8 special meeting where shareholders will vote on a reverse stock split (1-for-5 to 1-for-15) intended to restore compliance. With the stock trading at $1.25 today, the reverse split is the primary mechanism to lift the bid price above $1.00, but approval is not assured. A delisting would severely impair liquidity and investor access, compounding the company's existing going-concern and covenant-breach pressures.
How filings like this one have moved
In the 30 days to Sep 18, 2026, 40.1% of the 362 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.65%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, TELA was trading at $1.25 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $56.4M. The 52-week trading range was $0.50 to $1.69. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.